| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | Director | Stock option (right to buy) | 50,000 | 03 Mar 2025 | Direct | ||
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24,400 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:00 |
| CATX | Perspective Therapeutics, Inc. | 03 Mar 2025 | 1 | $0 | 4 | Director | 05 Mar 2025, 16:20 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 16:00 |
| CATX | Perspective Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 24 Jun 2024, 16:15 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 16:00 |
| CATX | Perspective Therapeutics, Inc. | 12 Dec 2023 | 1 | $0 | 4 | Director | 14 Dec 2023, 18:34 |
| CATX | Perspective Therapeutics, Inc. | 21 Feb 2023 | 2 | $0 | 4 | Director | 23 Feb 2023, 18:35 |
| CATX | Isoray, Inc. | 03 Feb 2023 | 0 | $0 | 3 | Director | 13 Feb 2023, 15:33 |
| CUE | Cue Biopharma, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 15:11 |
| CUE | Cue Biopharma, Inc. | 27 May 2022 | 1 | +$105,000 | 4 | Director | 31 May 2022, 16:06 |
| CUE | Cue Biopharma, Inc. | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 19:25 |